InTechOpen uses cookies to offer you the best online experience. By continuing to use our site, you agree to our Privacy Policy.

Biochemistry, Genetics and Molecular Biology » "Lipid Peroxidation", book edited by Angel Catala, ISBN 978-953-51-0716-3, Published: August 29, 2012 under CC BY 3.0 license. © The Author(s).

Chapter 5

Trends in the Evaluation of Lipid Peroxidation Processes

By Mihaela Ilie and Denisa Margină
DOI: 10.5772/46075

Article top


Implication of oxidative stress in pathology (“oxidative stress wheel”)
Figure 1. Implication of oxidative stress in pathology (“oxidative stress wheel”)
Sources, effects and main markers of oxidative stress
Figure 2. Sources, effects and main markers of oxidative stress
ROS neutralization by several biomolecules
Figure 3. ROS neutralization by several biomolecules
Generation of MDA as proposed by Esterbauer (1991)
Figure 4. Generation of MDA as proposed by Esterbauer (1991)
Mechanism of reaction for TBARS quantification
Figure 5. Mechanism of reaction for TBARS quantification
Obese patients with impaired plasma lipid profile (TC>220mg/dl, LDL>150mg/dl) are characterized by significantly different levels for the susceptibility of adipose tissue to induced lipid peroxidation as well as adiponectin level, compared to obese patients with normal plasma lipid profile (TC<220mg/dl, LDL<150mg/dl); * p<0.05 for cardio-vascular group compared to normal lipid profile group)
Figure 6. Obese patients with impaired plasma lipid profile (TC>220mg/dl, LDL>150mg/dl) are characterized by significantly different levels for the susceptibility of adipose tissue to induced lipid peroxidation as well as adiponectin level, compared to obese patients with normal plasma lipid profile (TC<220mg/dl, LDL<150mg/dl); * p<0.05 for cardio-vascular group compared to normal lipid profile group)
DPPP-oxide generation from Jurkat cell membrane before and after 20 minutes exposure to 10μM and 100 μM quercetin (Q) and epigallocatechin gallate (EGG) respectively; the fluorescence intensity was registered after 5 minutes of incubation of DPPP-labeled cells with CuOOH (for the induction of the lipid peroxidation)
Figure 7. DPPP-oxide generation from Jurkat cell membrane before and after 20 minutes exposure to 10μM and 100 μM quercetin (Q) and epigallocatechin gallate (EGG) respectively; the fluorescence intensity was registered after 5 minutes of incubation of DPPP-labeled cells with CuOOH (for the induction of the lipid peroxidation)

Trends in the Evaluation of Lipid Peroxidation Processes

Mihaela Ilie1 and Denisa Margină1

1. Introduction

Oxidative stress occurs as a result of imbalance between the antioxidant and prooxidant systems acting at certain points in metabolic processes, in favor of the last. The oxidative stress, defined by H Sies following extensive research performed between 1981 and 1993, is the outcome of intense generation of reactive oxygen species (ROS), which are not counteracted by endogenous antioxidant molecules [Sies, 1985]. Current knowledge links many types of pathologies to oxidative damage; among them, most cited are atherosclerosis, diabetes mellitus, neurodegenerative disorders, cancers, rheumatic diseases, autoimmune disorders, etc. Figure 1, sometimes referred to as “oxidative stress wheel”, presents the most important diseases in which oxidative stress is involved resulting in biochemical lessions

Free radicals are chemical species containing unpaired electrons, which can increase the reactivity of atoms or molecules. Free radicals are highly reactive and unstable, due to their impaired electrons; they can react locally, accepting or donating electrons, in order to become more stable. The reaction between a radical and a non-radical compound generally leads to the propagation of the radical chain reaction, and to an increasing generation of new free radicals. During biochemical processes that normally take place in living cells, many types of free radicals are generated: oxygen-, sulfur-, bromide- and chloride- centered species [Halliwell & Gutteridge, 2007]. The most common reported cellular free radicals are singlet oxygen (1Σg+O2), hydroxyl (OH ), superoxide (O2 ) and nitric monoxide (NO ). Also, some other molecules like hydrogen peroxide (H2O2) and peroxynitrite (ONOO) (which are not free radicals from the chemical point of view, having all-paired electrons) are reported to generate free radicals in living organisms through various chemical reactions [Halliwell, 2006].

In this context, it is extremely important to evaluate the extent and rate of the lipid peroxidation process using different methods and experimental models, ranging from quantitative assay of lipoperoxides end products to the evaluation of changes in certain metabolic processes under the influence of pro-oxidative or antioxidative known substances. The present article aims at reviewing different techniques, methods and experimental models for the evaluation of lipid peroxidation that can be used in clinical research and in basic biochemical research as well. Simple, rapid, cost effective, and more elaborated, expensive methods are critically evaluated, presenting the advantages and limitations of each one. A special emphasis is given to fluorescent methods, which our team is frequently using to evaluate the lipid peroxidation processes.


Figure 1.

Implication of oxidative stress in pathology (“oxidative stress wheel”)

2. Oxidative stress, ROS and implication in metabolic procesess

2.1. Oxygen centered reactive species (ROS)

Reactive oxigen species is a generic term that includes both oxygen radicals and certain non-radicals that are oxidizing agents and/or are easily converted into radicals, such as H2O2, ozone (O3), singlet oxygen (Δg1O2), peroxynitrite, hypochlorous acid (HOCl), etc. [Halliwell, 2006].

ROS are generated as a result of oxygen action on nutrients or on physiological components in living organisms.

The sources for oxidative stress are either endogenous (abnormal mithocondria and peroxisomes function, lipoxygenase, NADPH-oxidase, cytochrome P450 activity), endogenous antioxidant systems dysfunction (low amount of non-enzymatic antioxidants such as gluthatione, vitamins A, C and E, reduced enzimatic activity) or exogenous agents (ultraviolet or ionizing radiation, toxins, chemotherapy, bacteria, etc.) (Figure 2).


Figure 2.

Sources, effects and main markers of oxidative stress

ROS can induce many damaging cellular processes, such as DNA oxidative lesions, loss of membrane integrity due to lipid peroxidation, protein and functional carbohydrate structural changes, etc. All these structural and functional changes have direct clinical consequences, leading to the acceleration of the general aging process, but also to some pathological phenomena, associated with the increase of the capillary permeability, impairment of the blood cell function, etc. ROS lesions are frequently associated with aging [Dröge & Schipper, 2007; Griffiths et al., 2011], atheroclerosis [Hulsmans & Holvoet, 2010], cardio-vascular disease [Dikalov & Nazarewicz, 2012; Puddu et al., 2009], type I or type II diabetes mellitus [Cai et al., 2004], autoimmune disorders, neurodegenerative disorders such as Parkinson [Yoritaka et al., 1996] or Alzheimer’s disease [Sayre et al., 1997; Takeda et al., 2000], inflammatory diseases such as reumatoid arthritis [Griffiths et al., 2011] or different types of cancers [Lenaz, 2012; Li et al., 2009; Manda et al., 2009].

In order to counteract the damaging action of the physiologically generated ROS, the living organisms developed efficient antioxidant systems [Christofidou-Solomidou & Muzykantov 2006; Halliwell, 2006; Sies, 1997; Veskoukis et al., 2012]. Endogenous antioxidants in the human body act through different types of mechanisms:

  • reducing the ROS generation – through chelating the metal ions (ferum, copper, etc.) by specific or non-specific proteins (ferritine, transferrine, albumin), so that these ions can no longer participate to redox reactions [Aruoma et al., 1989; Elroy-Stein et al., 1986; Freinbichler, 2011; Halliwell & Gutteridge, 1984; Velayutham, 2011]

  • stopping the ROS formation chain reaction – generally via antioxidants with small molecular mass, such as reduced glutathion (GSH), vitamins E and C, uric acid, etc. [Gordon, 2012; Halliwell, 2006]

  • scavenging ROS with antioxidant enzymes such as superoxyde dismutase (SOD), catalase (CAT), glutathion-peroxidase (GPx), glutathion-reductatse (GR), etc. [Halliwell, 2006; Sies, 1997]

  • reparing lesions caused by ROS via specific enzymes such as endonucleases, peroxidases, lipases, etc. [Sies, 1997].

All these antioxidant systems act differently, depending on their structure and properties, their hydrophilic or lipophilic character, and also depending on their localization (intracellular or extracellular, in cell or organelles membrane, in the cytoplasm, etc.). All the aforementioned systems act sinergically and form a network which protects living cells from the destructive action of ROS (Figure 3).


Figure 3.

ROS neutralization by several biomolecules

2.2. Nitrogen centered radical species (RNS)

After the discovery of the physiological role of endogenously produced nitric oxide (NO), the capacity of this bio-molecule to react with other cellular components (such as proteins and lipids), specific nitrosative chemical changes have emerged as a key signaling mechanism in cell physiology. Several studies reported the involvement of excess generation of NO and its adducts in the etiology of multiple disease states, including insulin resistance and diabetes, atherosclerosis or Alzheimer’s disease [Duplain et al., 2008; Parastatidis et al., 2007; Uehara, 2007; Yasukawa T et al., 2005; White et al., 2010].

The nitrosative modifications of proteins take two main forms: either S-nitrosylation of cysteine thiols or nitration of tyrosine residues. Both chemical processes may arise from protein interactions with NO or with secondary intermediates of NO, otherwise termed reactive nitrogen species (RNS) [White et al., 2010]. One of the very important members of the RNS group is represented by peroxynitrite (ONOO-), produced from the reaction of NO with the superoxide anion (O2-), which is considered as one of the major cellular nitrating agents [Hogg, 2002; White et al., 2010]. Other nitrating agents are the nitrosonium cation (derived from the action of myeloperoxidase), produced from the reaction of nitrite with hydrogen peroxide and nitroso-peroxocarbonate, which results from the reaction of carbon dioxide with peroxynitrite. Lipid peroxyl radicals have been recently shown to promote tyrosine nitration by inducing tyrosine oxidation and also by reacting with NO2- to produce NO2 [Bartesaghi et al., 2010; Denicola et al., 1996; Lang et al., 2000].

2.3. Oxidative stress and lipid peroxidation

Among the targets of ROS and RNS, lipids are basically the most vulnerable, as their peroxidation products can result in further propagation of free radical reactions [Halliwell & Chirico, 1992]. The brain is a high oxygen-consuming organ and the nervous cell has also the greatest lipid-to-protein ratio; besides, the brain has a relatively week protection systems against ROS generation, therefore it is particularly vulnerable to oxidative stress. The age-related increase in oxidative brain damage results in intense generation of lipid peroxidation products, protein oxidation, oxidative modifications in nuclear and mitochondrial DNA [Grimsrud et al., 2008].

Polyunsaturated fatty acids (PUFAs) and their metabolites have many physiological roles such as energy generation, direct involvement in cellular and sub-cellular membrane structure and function, implication in cell signaling processes and in the regulation of gene expression as well. They constitute the main target of ROS action in the lipid peroxidation reactions.

The general process of lipid peroxidation consists of three stages: initiation, propagation, and termination [Auroma et al., 1989; Leopold & Loscalzo, 2009]. Many species can be responsible for the initiation of the chain reaction the radicals: hydroxyl, alkoxyl, peroxyl, superoxide or peroxynitrite. As a consequence, a free radical atracts a proton from a carbon of a fatty acyl side chain leaving the remaining carbon radical accessible to molecular oxygen to form a lipid peroxyl radical. This is also highly reactive and the chain reaction is propagated further. As a result, PUFA molecules are transformed into conjugated dienes, peroxy radicals and hydroperoxides, which will undergo a cleavage mainly to aldehydes. More than 20 lipoperoxidation end-products were identified [Niki, 2009]; among the components of PUFAs oxidative degradation products, the most frequently mentioned were acrolein, malondialdehyde (MDA), 4-hydroxyalkenals and isoprostanes [Esterbauer et al., 1991; Leopold & Loscalzo, 2009].

RNS also play a major role in lipid biology, by two major pathways: targeting some enzymes (COX-2 and cytochrome P-450) and thus influencing bioactive lipid synthesis and interacting with unsaturated fatty acids (such as oleate, linoleate and arachidonate) and generating novel nitro-fatty acids. Nitrated lipids, such as nitroalkenes, may undergo aqueous decay and release independent of thiols, isomerize to a nitrite ester with N-O bond cleavage, or generate an enol group and NO [Leopold & Loscalzo, 2009]. The nitro-fatty acids have distinct bioactivities from their precursor lipids [Baker et al., 2009; Freeman et al., 2008; Kim et al., 2005; Lee et al., 2008; White et al., 2010]. Studies identified a high number of nitro-fatty acid species and proved an elevated formation of RNS in hydrophobic environments, such as the lipid bilayer, suggesting that lipids might constitute candidates for nitrosative signal transduction [Jain et al., 2008; Moller et al., 2005; Moller et al., 2007; Thomas et al., 2001].

Nitroalkenes may also participate in reactions with cysteine and histidine residues in proteins and with the thiolate anion of glutathione (GSH) to initiate reversible modification(s) of proteins. Thiyl radicals may also initiate lipid peroxidation by extraction of a hydrogen atom from bis-allylic methylene groups of fatty acids generating pentadienyl radicals. These radicals, in turn, may react with oxygen to generate peroxyl radicals [Leopold & Loscalzo, 2009].

Lipid hydroperoxides (LOOHs) are intermediates of PUFAs lipid peroxidation and can be also found as minor constituents of cell membranes; these compounds are also final products of prostaglandin and leukotriene biosynthesis, and can be decomposed by transition metals to form alkoxyl and lipoperoxyl radicals. Furthermore, biomolecules such as proteins or amino-lipids, can be covalently modified by lipid decomposition products (i.e. by forming Schiff bases with aldehydes or/and by activating membrane-bound enzymes). In consequence, lipid peroxidation may alter the arrangement of proteins in bilayers and thereby interfere with their physiological role in the membrane function.

2.4. Pathological involvement of the lipid peroxidation process

Many lipid peroxidation products, either full chain or chain-shortened, have been reported to be harmful or to have pro-infl ammatory effects [Birukov 2006; Niki 2009; Salomon 2005].

Lipid peroxidation increases the permeability of cellular membranes, resulting in cell death.

The lipid peroxidation process located at the cell membrane level may lead to loss of integrity and viability, and also to altered cell signaling and finally to tissue dysfunction; the oxidation of plasma lipoproteins is probably a major contributor to the formation of lipid peroxidation products and is widely thought to be involved in atherosclerosis. Malondialdehyde and 4-hydroxy-2-nonenal (HNE), the well known products of lipid peroxidation, react with a variety of biomolecules, such as proteins, lipids and nucleic acids, and they are thought to contribute to the pathogenesis of human chronic diseases [Breusing et al., 2010].

A clear example of the pathological role of PUFAs peroxidation is the evolution of atherosclerotic lesions to cardio-vascular disease. Until 1970, it was considered that dyslipidemia was the main factor initiating the atherosclerotic lesions. Later on, researchers emphasized the involvement of inflammatory processes, growth factors, smooth muscle cells proliferation, as well as viruses, bacteria or tumor phenomenon in the atherosclerosis, besides lipids and lipoproteins.

RNS interaction with different types of proteins is directly involved in physio-pathological processes. Several studies proved that key enzymes involved in glycolysis, β-oxidation, the tricarboxylic acid cycle and electron transport chain are targets of tyrosine nitration or S-nitrosylation. Modifications by nitrosylation that reduce the activity or function of important tricarboxylic acid cycle and electron transport proteins have the potential to slow substrate oxidation and probably lead to the build up of metabolic intermediates (particularly lipids) that could impair signaling pathways to reduce insulin action. Also, key insulin-signaling intermediaries are S-nitrosylated, and this could constitute a potential mechanism of insulin resistance [Chouchani et al., 2010].

3. Evaluation of the end products of lipid peroxidation

Malonidialdehyde (MDA) is one of the most cited lipoperoxidation product originating from PUFAs. Several generation mechanisms have been proposed for MDA. Pryor & Stanley (1975) considered them as bicyclic endoperoxydes coming up from nonvolatiles MDA precursors, similar to prostaglandins. This mechanism was confirmed in 1983 by Frankel & Nef. Two other mechanisms were postulated by Esterbauer (1991) and consist in the successive generation of peroxydes and β-cleavage of the lipid chain or as a reaction of acroleine radical with a hydroxyl moiety (exemplification for arachidonic acid in Figure 4, adapted from Esterbauer, 1991). Hecker & Ulrich (1989) consider that MDA can be generated in vivo by means of enzymatic processes linked to prostaglandins.


Figure 4.

Generation of MDA as proposed by Esterbauer (1991)

Because the evaluation of the end products of lipid peroxidation at the tissue level is considered of maximum importance in both clinical and toxicological research, several methods to assay MDA have been proposed [Del Rio, 2005]. Since 1948, the most used method to assay lipoperoxidation end products is based on the studies of Bernheim et al., consisting in MDA condensation with the thiobarbituric acid (TBA) leading to a red complex which can be quantified by visible absorption spectrophotometry (in the range 500-600 nm, depending on the procedure used) or fluorescence spectroscopy (Figure 5). As TBA reacts also with several other aldehydes commonly present in the biological sample, the agents reacting with TBA are frequently denoted as thiobarbituric acid reacting species (TBARS). It must be said that TBARs and MDA are a rather imprecise measure of the lipid peroxidation process, since many substances that are present in human biological fluids can also react with TBA.

Moreover the reaction conditions (heating) can lead to the degradation of other molecules in the sample, increasing the amount of MDA that is available for the reaction with TBA. Therefore this assay usually gives an overestimation of free radical damage [Cherubini et al., 2005].


Figure 5.

Mechanism of reaction for TBARS quantification

The authors generally avoid interferences by using different methods: Kwiecieñ et al., 2002, used BHT (butylated hydroxytoluene) to prevent further oxidation of the sample; deproteinisation was performed with trichloracetic acid [Cassini et al., 1986], forced the lipoperoxidation and stopped the reaction with SDS and acetic acid [Gautam et al., 2010; Ohkawa et al., 1979], added EDTA and refered the results to standards prepared from tetramethoxypropane [Houglum et al., 1990] or used the standard addition method [Sprinteroiu et al., 2010].

The specificity of the measurement is improved by HPLC to separate the MDA-TBA adduct from interfering chromogens [Agarwal & Chase, 2002; Del Rio et al., 2003; Lykkersfeldt, 2001; Templar et al., 1999].

The principles of TBARS assay is so popular, that a few companies even developed kits for clinical research to assay MDA spectrophotometrically from biological samples.

Apart from the above mentioned method, other methods were applied for the quantitative assay of lipoperoxidation end-products: direct HPLC [Karatas et al., 2002], capillary electrophoresis [Wilson et al., 1997], RP-HPLC, derivatisation with 2,4-diphenylhydrazine [Sim et al., 2003], pre-column derivatisation with diaminonaphtalene at acidic pH (for protein bound MDA) or alkaline pH (for non protein-bound MDA), followed by HPLC-UV analysis [Stegens, 2001], GC-MS analysis following derivatisation with phenylhydrazine [Cighetti et al., 2002], GC-ECD-MS after derivatisation with 2,4,6-trichlorophenylhydrazine [Stalikas & Konidari, 2001].

4. Evaluation of the antioxidant status

For the evaluation of the antioxidant status in biological samples several markers (either enzymatic or non-enzymatic) can be used. Generally, the results obtained from the evaluation of antioxidant status markers should be correlated with certain peroxidative parameters, in order to be able to draw conclusions from the experiments.

Among the enzymatic markers of the antioxidant defense mechanism of the biological samples, literature cites some specific enzymes, such as catalase, superoxide-dismutase, glutathione-reductase, glutathione-peroxidase, etc. Each of these enzymes can be assayed using specific kits.

Commonly used are also non-enzyimatic markers, such as reduced glutathione, some vitamins (ascorbic acid, tocopherols, carotenoides).

A series of commercial kits for measuring the antioxidant status in biological samples (blood, serum, but also food products) are also available - the so-called total antioxidant status kits. The assays can be colorimetric (one example is the kit using as a chromogen 2,2’-azino-di-[3-ethylbenzthiazole sulfonate], which reacts with methmyoglobin and hydrogen peroxide to give a coloured cation), chemiluminometric (using the reaction of luminol with hydrogen peroxyde), or physico-chemical (potentiometric).

These methods allow the evaluation of the total antioxidant capacity in the biological samples, thus accounting both for enzymatic and for non-enzymatic bio-molecules.

Our group developed a method enabling a distinct evaluation for the biological samples antioxidant capacity as resulting exclusively from redox hydrophilic biomolecules. The method is based on potentiometric evaluation of the status of oxidant and reducing species in samples of human serum. We used a micro Pt/AgCl combination redox electrode, with an internal reference, and a Tistand 727 Potentiometer (Metrohm AG, Switzerland). The baseline apparent redox potential of the human serum (ARP0) was measured; than a mild prooxidant chemical system (quinhydrone) was added to the biological samples. After incubating at 25˚C for 1h respectively 3 hours, two final apparent redox potentials were recorded (ARPf). Quinhydrone mimics the prooxidant conditions developing in vivo and consumes the reducing species leading to an increase of the apparent redox potential in time. This dynamic recording of the data allowed the calculation of a difference between the final value of the ARP (ARPf) and the initial one (ARP0), thus defining the redox stability index (RSI). This parameter illustrates the serum sample capacity to counteract the prooxidant agent. The lower the RSI, the higher the activity of the hydrosoluble antioxidant protective systems in the serum [Margina et al., 2009].

5. Monitoring the induced-peroxidation process

J. Goldstein, M. Brown, and D, Steinberg emphasized more than a decade ago, that low density lipoproteins can be chemically modified, loosing their ability to be recognized by the classical LDL receptors [Brown & Jessup, 1999; Steinberg, 2009]. The oxidation of LDL does not take place in the blood stream, but inside the intimae, after lipoprotein complexes crossing through the endothelium. Therefore, in the oxidation process intracellular as well as extra cellular components are involved. This change of the LDL is realized mainly by oxidation with the free radicals that appear in large amounts in hypertension, diabetes mellitus, as a consequence of smoking, or in viral and bacterial infections, but LDL may be also modified by glycation (in type II diabetes mellitus), by association with proteoglycans or by incorporation in immune complexes [Ross, 1999].

Oxidised LDL particles (LDLox) have been proved to have different proatherogenic effects that can be predominantly attributed to their lipid components. Mainly, the uptake of LDLox by macrophages is enhanced through the scavenger receptor. Products generated from the decomposition of peroxidized lipids, such as aldehydes, modify the apolipoprotein B-100 (apoB-100) structure to a more electronegative form able to interact with the macrophage scavenger receptor. The modified LDL particles are taken up by scavenger receptors on the macrophages instead of the classical LDL receptors. This process is not regulated by feed back inhibition and allows the excessive build-up of cholesterol inside the cells, leading to their transformation into foam cells that are involved in the initiation and progression of atherosclerotic lesion [Parthasarathy et al., 1999; Shamir, 1996].

Alpha-tocopherol is an antioxidant from the LDL structure, and is the first one degraded during the radical attack on these lipoproteins. When this antioxidant protection is exhausted, PUFA are changed into lipid hydroperoxides. There is a great variability between subjects regarding the amount of PUFA and of antioxidants from LDL, which explains the variability concerning the susceptibility to oxidation of LDL particles. There are also a lot of other factors that influence in vitro evaluation of LDLox: some endogenous compounds, diet, some medicines, and probably genetic factors. Therefore, the assay of the in vitro LDL susceptibility to lipid peroxidation constitutes an important marker in the evaluation of atherogenic models/patients [Parthasarathy et al., 1999; Shamir, 1996].

The susceptibility of lipoprotein particles to lipid peroxidation can be assessed, after the isolation of LDL, either by treatment with copper salts, with mixtures of ferric compounds and ascorbic acid, or other prooxidant systems.

In order to evaluate this susceptibility to oxidation Esterbauer et al. proposed in 1989 a method based on the variation of absorbance of conjugated dienes in time at 234 nm. These dienes are relatively stable products resulted by a rearrangement of the double bonds from the PUFA molecules after the radical hydrogen abstraction. The increase in absorption at 234 nm is due to the formation of conjugated dienes during the peroxidation of polyunsaturated fatty acids. Absorbance at 234 nm shows an initial slower increase (lag phase) as antioxidants are destroyed and then increases more rapidly (propagation phase) reaching a plateau phase at which the absorbance is maximal as the rate of formation of dienes approaches their rate of decomposition [Esterbauer et al., 1990].

Another method for the assay of lipoprotein susceptibility to lipid peroxidation is based on the ability of lipid hydroperoxides to convert iodide (I-) to iodine (I2), which will than react with the iodide excess and form I3- that absorbs at 365 nm. There is a direct stoechiometric relationship between the amount of organic peroxides that resulted from the reaction and the concentration of I3- [Steinberg D., 1990, Esterbauer H. 1993]

One of the symplest methods for the assay of the susceptibility of LDL particles to lipid peroxidation is based on the selective precipitation of serum LDL with heparin at isoelectrical point (pH=5.4), method which is cheaper and quicker than the one based on ultracentrifugation. Personal results proved that the susceptibility of LDL to lipid peroxidation is correlated with the fasting plasma glucose level as well as with the lipid level [Margina et al., 2004].

The same type of assay can be used in order to evaluate the susceptibility to induced peroxidation for other kinds of biological samples (red blood cells, sub-cellular fractions such as mitochondria, or even tissue homogenates).

Previously published results [Margina D et al., 2011] proved that, for patients diagnosed with central obesity (BMI>30Kg/m2), adipose tissue susceptibility to lipid peroxidation correlated significantly with the total cholesterol (TC) level and with the LDL level. The susceptibility of adipose tissue to lipid peroxidation was assessed on white adipose tissue harvested from the abdominal area, homogenated in NaOH 0.015M, followed by TBARS evaluation. This parameter reflects the tendency to accumulation of free radicals in the adipose tissue of obese patients. In the same study, we pointed out that patients with impaired lipid profile (TC>220 mg/dl, LDL>150 mg/dl) had a significantly higher susceptibility of the adipose tissue to lipid peroxidation (p=0.036), associated with the decrease of the adiponectin level (Figure 6), compared to obese patients with physiologic lipid profile (TC<220mg/dl, LDL<150mg/dl).

Literature data also mention the assay of circulating LDLox, using different ELISA methods; one of these methods uses antibodies against a conformational epitope in the apolipoprotein B-100 (apoB-100) moiety of LDL that is generated as a consequence of substitution of at least 60 lysine residues of apoB-100 with aldehydes. This number of substituted lysines corresponds to the minimal number required for scavenger-mediated uptake of ox-LDL. The substituting aldehydes can be produced by peroxidation of lipids of LDL, leading to the generation of ox-LDL [Holvoet et al., 2006]. Another method might be the electrophoretic separation of LDL and LDLox particles from serum samples; studies proved that the electrophoretic mobility of oxidized LDL particles is increased compared to that of standard LDL [Lougheed et al., 1996].


Figure 6.

Obese patients with impaired plasma lipid profile (TC>220mg/dl, LDL>150mg/dl) are characterized by significantly different levels for the susceptibility of adipose tissue to induced lipid peroxidation as well as adiponectin level, compared to obese patients with normal plasma lipid profile (TC<220mg/dl, LDL<150mg/dl); * p<0.05 for cardio-vascular group compared to normal lipid profile group)

Besides biochemical determination, noninvasive, real-time monitoring of lipid peroxidation using fluorescent probes has also been developed. The assays can be performed either on living cells (for example using cis-parinaric acid, fluoresceinated phosphoethanolamine, undecylamine-fluorescein, diphenyl-1-pyrenylphosphine – DPPP or other fluorescent markers) or non-living samples (liposomes, tissue homogenates, plasma, serum, etc). In the cases of experiments that are performed on living cells, common limitation of use of fluorescent probes is that the probes often are cytotoxic or affect physiological activities of the cell [Drummen et al., 2004; Margina et al., 2012, Takahashi M. et al., 2001]. DPPP stoichiometrically reduces biologically generated hydroperoxides (such as fatty acid hydroperoxides, and triacylglycerol hydroperoxides) to their corresponding alcohols, and is transformed consequently into its oxide. DPPP is essentially non-fluorescent until oxidized to a phosphine-oxide by peroxides. Due to its solubility in lipids, DPPP intercalates into the membrane leaflets and reacts with lipid hydroperoxides, thus allowing the evaluation of peroxide formation in the membranes of live cells [Kawai et al., 2007]. Due to these chemical properties, the probe can be used in order to evaluate the extent of lipid peroxidation of biological materials such as cell membranes [Akasaka et al., 1993; Ohshima et al., 1996; Takahashi et al., 2001]. Because DPPP molecules are incorporated into the cell membranes, hydroperoxides located in the membrane are supposed to preferably react with DPPP.

Diphenyl-1-pyrenylphosphine (DPPP) is a synthetic compound with high reactivity against hydroperoxides, which has been used as a sensitive fluorescent probe for hydroperoxide analysis for HPLC methods. H2O2, which is least lipid-soluble, does not induce the peroxidation reaction of DPPP located in cell membranes. Although H2O2 is highly permeable to the membrane, it may not stay within the membrane long enough to react with DPPP effectively. Experimental lipid peroxidation can be induced by 10µM cumene hydroperoxide (CuOOH) which generates an effective reaction with DPPP in the membrane [Gomes et al., 2005; Takahashi et al., 2001].

We proved using DPPP in cell models (U937 human macrophage cell line as well as Jurkat lymphocytic cells) that the increase of certain polyphenol concentration (quercetin or epigallocatechin gallate) induces a decrease of the CuOOH induced lipid peroxidation of cell membranes. Fluorescence signals for the cells labeled with 5 μM DPPP are presented in Figure 7 [Margina et al, 2012].


Figure 7.

DPPP-oxide generation from Jurkat cell membrane before and after 20 minutes exposure to 10μM and 100 μM quercetin (Q) and epigallocatechin gallate (EGG) respectively; the fluorescence intensity was registered after 5 minutes of incubation of DPPP-labeled cells with CuOOH (for the induction of the lipid peroxidation)

6. Conclusions

Oxidative stress is among the most claimed causes of disease, as by its very definition indicates an abnormal biochemical function of the body. Among the targets of the oxidative stress, lipids are favorites, susceptible to structural changes that can decisively influence their normal function, and also generating hydroxyperoxides that further propagate the lipoperoxidation process.

Lipid peroxidation has been intensively studied in connection with normal and pathological metabolic processes; one of the main purposes was the understanding of toxicity triggered by lipoperoxidation end-products. That is why direct or indirect quantification of these products (TBARS, MDA, hydroxynonenals, prostaglandins, DNA and protein-adducts of the former, etc.) remains of interest for traditional and nowadays methods. The process of lipoperoxidation is often monitored in dynamics, even on living cells, using various techniques.

It is also of a great interest to seek for efficient antioxidants to prevent the excess lipoperoxidation, therefore one component of such kind of studies consist in finding out efficient markers for the oxidative stress and the antioxidant status. This can be fulfilled if a right and comprehensive understanding of the lipoperoxidation process is achieved. But this is still a faraway target.


The work was performed under the CNCSIS grant PD 132/30.07.2010 (PD 29/2010).


1 - R. Agarwal, S. D. Chase, 2002Rapid, fluorimetric-liquid chromatographic determination of malondialdehyde in biological samples. J Chromatogr B, 77511570-0232
2 - K. Akasaka, H. Ohrui, H. Meguro, M. Tamura, 1993Determination of triacylglycerol and cholesterol ester hydroperoxides in human plasma by high-performance liquid chromatography with fluorometric postcolumn detection.J. Chromatogr. B 6172205 EOF11 EOF0000-1570
3 - O. I. Aruoma, B. Halliwell, M. J. Laughton, G. J. Quinlan, J. M. C. Gutteridge, 1989The mechanism of initiation of lipid peroxidation. Evidence against a requirement for an iron(II)-iron(III) complex.Biochem. J. 25820264-6021
4 - P. R. Baker, F. J. Schopfer, V. B. O’Donnell, B. A. Freeman, 2009Convergence of nitric oxide and lipid signaling: anti-inflammatory nitro-fatty acidsFree Radic Biol Med 468989 EOF1003 EOF0891-5849
5 - S. Bartesaghi, J. Wenzel, M. Trujillo, M. Lopez, J. Joseph, B. Kalyanaraman, R. Radi, 2010Lipid peroxyl radicals mediate tyrosine dimerization and nitration in membranesChem Res Toxicol 234821 EOF835 EOF1520-5010
6 - H. Benkhai, S. Lemanski, H. Below, J. U. Heiden, E. Below, J. Lademann, M. Bornewasser, T. Balz, C. Chudaske, A. Kramer, 2010Can physical stress be measured in urine using the parameter antioxidative potential? GMS Krankenhaushyg Interdiszip. 52Doc03.DOI:dgkh000146 1863-5245
7 - F. Bernheim, M. L. C. Bernheim, K. M. Wilbur, 1948The reaction between thiobarbituric acid and the oxidation products of certain lipids. J Biol Chem, 1740021-9258
8 - Birukov KG.2006Oxidized lipids: the two faces of vascular inflammationCurr Atheroscler Rep 83223 EOF231 EOF1534-6242
9 - A. J. Brown, W. Jessup, 1421 EOF28 EOF0021-9150
10 - W. Cai, J. C. He, L. Zhu, M. Peppa, C. Lu, J. Uribarri, H. Vlassara, 2004High Levels of Dietary Advanced Glycation End Products Transform Low-Density Lipoprotein Into a Potent Redox-Sensitive Mitogen-Activated Protein Kinase Stimulant in Diabetic Patients Circulation, 11030009-7322
11 - A. F. Casini, M. Ferrali, A. Pompella, E. Maellaro, M. Comporti, 1986Lipid Peroxidation and Cellular Damage in Extrahepatic Tissues of Bromobenzene-Intoxicated Mice.Am J Pathol, 123520 EOF31 EOF0002-9440
12 - A. Cherubini, C. Ruggiero, M. C. Polidori, P. Mecocci, 2005Potential markers of oxidative stress in stroke.Free Radic Biol Med 397841 EOF52 EOF0891-5849
13 - E. T. Chouchani, T. R. Hurd, S. M. Nadtochiy, P. S. Brookes, I. M. Fearnley, K. S. Lilley, R. A. Smith, M. P. Murphy, 2010Identification of S-nitrosated mitochondrial proteins by S-nitrosothiol difference in gel electrophoresis (SNO-DIGE): implications for the regulation of mitochondrial function by reversible S-nitrosationBiochem J 430149 EOF59 EOF0264-6021
14 - M. Christofidou-Solomidou, V. R. Muzykantov, 2006Antioxidant Strategies in Respiratory Medicine,Treat Respir Med 5147 EOF78 EOF1176-3450
15 - G. Cighetti, P. Allevi, L. Anastasia, L. Bortone, R. Paroni, 2002Use of methyl malondialdehyde as an internal standard for malondialdehyde detection: validation by isotope-dilution gas chromatography-mass spectrometry.Clin Chem 48122266 EOF9 EOF1530-8561
16 - D. Del Rio, N. Pellegrini, B. Colombi, M. Bianchi, M. Serafini, F. Torta, M. Tegoni, M. Musci, 2003Rapid fluorimetric method to detect total plasma malondialdehyde with mild derivatization conditions.Clin Chem, 494690 EOF2 EOF1530-8561
17 - A. Denicola, B. A. Freeman, M. Trujillo, R. Radi, 1996Peroxynitrite reaction with carbon dioxide/bicarbonate: kinetics and influence on peroxynitrite mediated oxidations.Arch Biochem Biophys 333149 EOF58 EOF0003-9861
18 - Dikalov S.I. & Nazarewicz R.R.2012Angiotensin II-induced production of mitochondrial ROS: Potential mechanisms and relevance for cardiovascular disease. Antioxid Redox Signal. Mar 24. [Epub ahead of print], 1557-771615577716
19 - W. Dröge, H. M. Schipper, 2007Oxidative stress and aberrant signaling in aging and cognitive declineAging Cell 631474-9718
20 - G. P. Drummen, M. Makkinje, A. J. Verkleij, den. Op, J. A. Kamp, J. A. Post, 2004Attenuation of lipid peroxidation by antioxidants in rat-1 fibroblasts: comparison of the lipid peroxidation reporter molecules cis-parinaric acid and C11-BODIPY(581/591) in a biological setting. Biochim Biophys Acta. 16362-3
21 - H. Duplain, C. Sartori, P. Dessen, P. Y. Jayet, M. Schwab, J. Bloch, P. Nicod, U. Scherrer, 2008Stimulation of peroxynitrite catalysis improves insulin sensitivity in high fat diet-fed miceJ Physiol 586164011 EOF4016 EOF1469-7793
22 - J. P. Eiserich, M. Hristova, C. E. Cross, A. D. Jones, B. A. Freeman, B. Halliwell, A. van der Vliet, 1998Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils.Nature3916665393 EOF7 EOF1476-4687
23 - O. Elroy-Stein, Y. Bernstein, Y. Groner, 1986Overproduction of human Cu/Zn-superoxide dismutase in transfected cells: extenuation of paraquat-mediated cytotoxicity and enhancement of lipid peroxidation.EMBO J 53615 EOF22 EOF0261-4189
24 - H. Esterbauer, 1993Cytotoxicity and genotoxicity of lipid-oxydation products, Am. J. Clin. Nutr., 5750002-9165
25 - H. Esterbauer, M. Dieber-Rothender, G. Waeg, G. Striegl, G. Jurgens, 1990Biochemical, structural, and functional properties of oxidized low-density lipoproteins. Chem. Res. Toxicol., 320089-3228X.
26 - H. Esterbauer, R. J. Schaur, H. Zollner, 1991Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes.Free Radic Biol Med, 11181 EOF128 EOF0891-5849
27 - Frankel E.N. & Neff W.E.1983Formation of malonaldehyde from lipid oxidation products, Biochim Biophys Acta 75430006-3002
28 - B. A. Freeman, P. R. Baker, F. J. Schopfer, S. R. Woodcock, A. Napolitano, M. d’Ischia, 2008Nitro-fatty acid formation and signalingJ Biol Chem 282315515 EOF15519 EOF0108-3351X.
29 - W. Freinbichler, M. A. Colivicchi, C. Stefanini, L. Bianchi, C. Ballini, B. Misini, P. Weinberger, W. Linert, D. Varešlija, K. F. Tipton, L. Della Corte, 2011Highly reactive oxygen species: detection, formation, and possible functions. Cell Mol Life Sci. 68120142-0682X.
30 - N. Gautam, S. Das, S. K. Mahapatra, S. P. Chakraborty, P. K. Kundu, S. Roy, 2010Age associated oxidative damage in lymphocytesOxidative Medicine and Cellular Longevity 341942-0900
31 - A. Gomes, E. Fernandes, J. L. F. C. Lima, 2005Fluorescence probes used for detection of reactive oxygen species.J. Biochem. Biophys. Methods 652-345 EOF80 EOF0016-5022X
32 - Gordon M.H.2012Significance of Dietary Antioxidants for HealthInt. J. Mol. Sci., 13173-1791422-0067
33 - H. R. Griffiths, C. R. Dunston, S. J. Bennett, M. M. Grant, D. C. Phillips, G. D. Kitas, 2011Free radicals and redox signalling in T-cells during chronic inflammation and ageingBiochem Soc Trans. 3951273 EOF1278 EOF0300-5127
34 - P. A. Grimsrud, H. Xie, T. J. Griffin, D. A. Bernlohr, 2008Oxidative Stress and Covalent Modification of Protein with Bioactive AldehydesJ Biol Chem 2833221837 EOF21841 EOF0021-9258
35 - B. Halliwell, S. Chirico, (l993, peroxidation. Lipid, mechanism. its, measurement, J. significance, Nutr. Clin, 57(suppl. Vol, No, 71552551938-3207
36 - B. Halliwell, J. M. C. Gutteridge, 1984Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 21910264-6021
37 - B. Halliwell, 1992Reactive oxygen species and the central nervous system.J. Neurochem. 5951609 EOF23 EOF0022-3042
38 - B. Halliwell, J. M. C. Gutteridge, 2007Free radicals in Biology and Medicine4th edition Oxford University Press, 978-0-19856-869-8New York.
39 - B. Halliwell, 2006Reactive Species and Antioxidants. Redox Biology Is a Fundamental Theme of Aerobic Life. Plant Physiology, 14120981-9428
40 - M. Hecker, V. Ullrich, 1989On the mechanism of prostacyclin and thromboxane A2 biosynthesis.J Biol Chem 2641141 EOF50 EOF0108-3351X.
41 - N. Hogg, 2002The biochemistry and physiology of S-nitrosothiols.Annu Rev Pharmacol Toxicol 42585 EOF600 EOF0362-1642
42 - P. Holvoet, E. Macy, M. Landeloos, D. Jones, J. S. Nancy, Van de Werf, Tracy R.2006Analytical Performance and Diagnostic Accuracy of Immunometric Assays for the Measurement of Circulating Oxidized LDL.Clinical Chemistry5241530-8561
43 - K. Houglum, M. Filip, J. L. Witztum, M. Chojkier, 1990Malondialdehyde and 4-Hydroxynonenal Protein Adducts in Plasma and Liver of Rats with Iron Overload.J. Clin. Invest. 861991 EOF8 EOF0021-9738
44 - M. Hulsmans, P. Holvoet, 2010The vicious circle between oxidative stress and inflammation in atherosclerosis.J Cell Mol Med 141-270 EOF8 EOF1422-0067
45 - K. Jain, A. Siddam, A. Marathi, U. Roy, J. R. Falck, M. Balazy, 2008The mechanism of oleic acid nitration by 2Free Radic Biol Med, 45No 3, 269-283, 0891-5849
46 - F. Karatas, M. Karatepe, A. Baysar, 2002Determination of free malondialdehyde in human serum by high-performance liquid chromatographyAnal Biochem, 31176 EOF79 EOF1096-0309
47 - Y. Kawai, M. Miyoshi, J. H. Moon, J. Terao, 2007Detection of cholesteryl ester hydroperoxide isomers using gas chromatography-mass spectrometry combined with thin-layer chromatography blottingAnal. Biochem. 3601130 EOF137 EOF1096-0309
48 - S. F. Kim, D. A. Huri, S. H. Snyder, 2005Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2.Science 31057561966 EOF70 EOF0036-8075
49 - S. Kwiecieñ, T. Brzozowski, P. Konturek, Ch, S. J. Konturek, 2002The role of reactive oxygen species in action of nitric oxide-donors on stress-induced gastric mucosal lesions.Journal of Physiology and Pharmacology, 534761 EOF73 EOF0867-5910
50 - J. D. Lang, P. Jr Chumley, J. P. Eiserich, A. Estevez, T. Bamberg, A. Adhami, J. Crow, B. A. Freeman, 2000Hypercapnia induces injury to alveolar epithelial cells via a nitric oxide-dependent pathway.Am J Physiol Lung Cell Mol Physiol 2795L994 EOF1002 EOFL1002, 1522-1504
51 - G. Lenaz, 2012Mitochondria and reactive oxygen species. Which role in physiology and pathology? Adv Exp Med Biol. 9420065-2598
52 - J. A. Leopold, L. Loscalzo, 2009Oxidative Risk for Atherothrombotic Cardiovascular DiseaseFree Radic Biol Med. 47121673 EOF1706 EOF0891-5849
53 - Y. Liu, D. R. Schubert, 2009The specificity of neuroprotection by antioxidantsJ Biomed Sci 161021-7770
54 - M. Lougheed, U. P. Steinbrecher, 1996Mechanism of Uptake of Copper-oxidized Low Density Lipoprotein in Macrophages Is Dependent on Its Extent of Oxidation,J Biol Chem 2712011798 EOF805 EOF0108-3351X
55 - J. Lykkersfeld, 2001Determination of Malondialdehyde as Dithiobarbituric Acid Adduct in Biological samples by HPLC with fluorescence detection: Comparison with Ultraviolet-Visible Spectrophotometry. Clin Chem, 4791530-8561
56 - G. Manda, M. T. Nechifor, T. M. Neagu, 2009Reactive Oxygen Species, Cancer and Anti-Cancer Therapies. Current Chemical Biology 311872-3136
57 - D. Margina, D. Gradinaru, C. Panaite, D. Cimponeriu, M. Vladica, R. Danciulescu, N. Mitrea, 2011The association of adipose tissue markers for redox imbalance and the cardio-vascular risk in obese patients, HealthMED 511840-2291
58 - D. Margina, D. Gradinaru, N. Mitrea, 2004Clinical study regarding the atherogenic properties of the oxidatively modified low-density lipoproteins. Archives of the Balkan Medical Union, 3920041-6940
59 - D. Margina, D. Gradinaru, N. Mitrea, 2009Development of a potentiometric method for the evaluation of redox status in human serumRevue Roumaine de Chimie54145 EOF48 EOF0035-3930
60 - M. Moller, H. Botti, C. Batthyany, H. Rubbo, R. Radi, A. Denicola, 2005Direct measurement of nitric oxide and oxygen partitioning into liposomes and low density lipoprotein.J Biol Chem 280108850 EOF4 EOF0108-3351X.
61 - M. N. Moller, Q. Li, J. R. Lancaster, Jr , A. Denicola, 2007Acceleration of nitric oxide autoxidation and nitrosation by membranes.IUBMB Life594-5243 EOF8 EOF1521-6551
62 - E. Niki, 2009Lipid peroxidation: physiological levels and dual biological effectsFree Radic Biol Med; 475469 EOF484 EOF0891-5849
63 - H. Ohkawa, N. Ohishi, K. Yagi, 1979Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.Anal Biochem 952351 EOF8 EOF1096-0309
64 - T. Ohshima, A. Hopia, J. B. German, E. N. Frankel, 1996Determination of hydroperoxides and structures by high-performance liquid chromatography with post-column detection with diphenyl-1-pyrenylphosphine.Lipids31101091 EOF6 EOF1558-9307
65 - I. Parastatidis, L. Thomson, D. M. Fries, R. E. Moore, J. Tohyama, X. Fu, S. L. Hazen, H. F. Heijnen, M. K. Dennehy, D. C. Liebler, D. J. Rader, H. Ischiropoulos, 2007Increased protein nitration burden in the atherosclerotic lesions and plasma of apolipoprotein A-I deficient mice. Circ Res 10140009-7330
66 - S. Parthasarathy, N. Santanam, S. Ramachandran, O. Meilhac, 1999Oxidants and antioxidants in atherogenesis: an appraisal,J. Lipid Res. 40122143 EOF57 EOF1539-7262
67 - Pryor W.A. & Stanley J.P.1975A suggested mechanism for the production of malonaldehyde during the autoxidation of polyunsaturated fatty acids. Nonenzymatic production of prostaglandin endoperoxides during autoxidation. J Org Chem 40243615 EOF7 EOF1099-0690
68 - P. Puddu, G. M. Puddu, E. Cravero, S. De Pascalis, A. Muscari, 2009The emerging role of cardiovascular risk factor-induced mitochondrial dysfunction in atherogenesis J. Biomed Sci 161021-7770
69 - Rizzo M.A. & Piston D.W.2003Regulation of beta cell glucokinase by S-nitrosylation and association with nitric oxide synthase.J Cell Biol 1612243 EOF8 EOF1540-8140
70 - R. Ross, 1999Atherosclerosis-an Inflammatory Disease, NEJM, 3402115 EOF26 EOF1533-4406
71 - Salomon RG.2005Isolevuglandins, oxidatively truncated phospholipids, and atherosclerosis. Ann NY Acad Sci 10430000-1749
72 - L. M. Sayre, D. A. Zelasko, P. L. Harris, G. Perry, R. G. Salomon, MA Smith, 19974-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer’s disease.J. Neurochem. 6852092 EOF7 EOF0022-3042
73 - R. Shamir, W. Johnson, K. Morlock-Fitzpatrick, R. Zolfaghari, Li. Ling, E. Mas, D. Lombardo, D. W. Morel, E. A. Fisher, 1996Pancreatic Carboxyl Ester Lipase: A Circulating Enzyme That Modifies Normal and Oxidized Lipoproteins In Vitro,J Clin Invest 9770000-1365
74 - H. Sies, 1997Oxidative stress: oxidants and antioxidants.Experim Phys 8220144-8757
75 - H. Sies, 1985Oxidative stress: introductory remarks. In: Oxidative Stress. H. Sies, (Ed.). Academic Press, 17978-0-12642-760-8London
76 - A. S. Sim, C. Salonikas, D. Naidoo, D. E. Wilcken, 2003Improved method for plasma malondialdehyde measurement by high-performance liquid chromatography using methyl malondialdehyde as an internal standard.J Chromatogr B 7852337 EOF44 EOF0000-1570
77 - M. Sprinteroiu, D. Balalau, C. M. Gutu, M. Ilie, C. Petraru, 2010Quantitative analysis of malondialdehyde in normal human plasma using fluorescence and the standard addition methodFarmacia584509 EOF510 EOF0014-8237
78 - Stalikas C.D. & Konidari C.N.2001Analysis of malondialdehyde in biological matrices by capillary gas chromatography with electron-capture detection and mass spectrometryAnal Biochem 2901108 EOF115 EOF1096-0309
79 - J. P. Steghens, A. L. van Kappel, I. Denis, C. Collombel, 2001Diaminonaphthalene, a new highly specific reagent for HPLC-UV measurement of total and free malondialdehyde in human plasma or serum. Free Radic Biol Med, 3120891-5849
80 - D. Steinberg, 1990Arterial metabolism of lipoproteins in relation to atherogenesis.Ann N Y Acad Sci, 598125 EOF35 EOF1749-6632
81 - D. Steinberg, 2009The LDL modification hypothesis of atherogenesis: an updateJ. Lipid Res. 50S), S376-S381, 0022-2275
82 - M. Takahashi, M. Shibata, E. Niki, 2001Estimation of lipid peroxidation of live cells using a fluorescent probe, Diphenyl-1-pyrenylphosphine.Free Rad. Biol. Med. 312164 EOF74 EOF1873-4596
83 - A. Takeda, M. A. Smith, J. Avila, A. Nunomura, S. L. Siedlak, X. Zhu, G. Perry, L. M. Sayre, 2000In Alzheimer’s disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2- nonenal modification. J. Neurochem. 7530022-3042
84 - J. Templar, S. P. Kon, T. P. Milligan, D. J. Newman, M. J. Raftery, 1999Increased plasma malondialdehyde levels in glomerular disease as determined by a fully validated HPLC method.Nephrol Dial Transplant, 144946 EOF51 EOF0931-0509
85 - D. D. Thomas, X. Liu, S. P. Kantrow, J. R. Lancaster, Jr , 2001The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O2Proc Natl Acad Sci USA 9811091-6490
86 - T. Uehara, 2007Accumulation of misfolded protein through nitrosative stress linked to neurodegenerative disordersAntioxid Redox Signal 95597 EOF601 EOF1557-7716
87 - M. Velayutham, C. Hemann, J. L. Zweier, 2011Removal of H₂O₂ and generation of superoxide radical: role of cytochrome c and NADH. Free Radic Biol Med. 5110891-5849
88 - A. S. Veskoukis, A. M. Tsatsakis, D. Kouretas, 2012Dietary oxidative stress and antioxidant defense with an emphasis on plant extract administrationCell Stress and Chaperones 17111 EOF21 EOF1355-8145
89 - P. J. White, A. Charbonneau, G. J. Cooney, A. Marette, 2010Nitrosative modifications of protein and lipid signaling molecules by reactive nitrogen speciesAm J Physiol Endocrinol Metab, 2996E868 EOFE878, 0193-1849
90 - D. W. Wilson, H. N. Metz, L. M. Graver, P. S. Rao, 1997Direct method for quantification of free malondialdehyde with high-performance capillary electrophoresis in biological samples.Clin Chem. 43101982 EOF4 EOF1530-8561
91 - T. Yasukawa, E. Tokunaga, H. Ota, H. Sugita, J. A. Martyn, M. Kaneki, 2005S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance.J Biol Chem 28097511 EOF8 EOF0108-3351X
92 - A. Yoritaka, N. Hattori, K. Uchida, M. Tanaka, E. R. Stadtman, Y. Mizuno, 1996Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson diseasePNAS 9372696 EOF1091-6490